BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22985027)

  • 1. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
    Zhang Q; Lu Y; Ding Y; Zhai J; Ji Q; Ma W; Yang M; Fan H; Long J; Tong Z; Shi Y; Jia Y; Han B; Zhang W; Qiu C; Ma X; Li Q; Shi Q; Zhang H; Li D; Zhang J; Lin J; Li LY; Gao Y; Chen Y
    J Med Chem; 2012 Oct; 55(20):8757-69. PubMed ID: 22985027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells.
    Ding YH; Fan HX; Long J; Zhang Q; Chen Y
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6087-92. PubMed ID: 24095093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
    Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
    Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.
    Ji Q; Ding YH; Sun Y; Zhang Y; Gao HE; Song HN; Yang M; Liu XL; Zhang ZX; Li YH; Gao YD
    Oncotarget; 2016 Oct; 7(40):65012-65023. PubMed ID: 27542251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
    Ding YH; Gao X; Long J; Kuang BJ; Chen Y; Zhang Q
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1165-8. PubMed ID: 26832219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of micheliolide derivatives and their activities against AML progenitor cells.
    Ma WW; Shi QQ; Ding YH; Long J; Zhang Q; Chen Y
    Molecules; 2013 May; 18(5):5980-92. PubMed ID: 23698050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
    J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation.
    Hong Z; Xiao M; Yang Y; Han Z; Cao Y; Li C; Wu Y; Gong Q; Zhou X; Xu D; Meng L; Ma D; Zhou J
    Carcinogenesis; 2011 Oct; 32(10):1550-8. PubMed ID: 21803735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.
    Saito Y; Yuki H; Kuratani M; Hashizume Y; Takagi S; Honma T; Tanaka A; Shirouzu M; Mikuni J; Handa N; Ogahara I; Sone A; Najima Y; Tomabechi Y; Wakiyama M; Uchida N; Tomizawa-Murasawa M; Kaneko A; Tanaka S; Suzuki N; Kajita H; Aoki Y; Ohara O; Shultz LD; Fukami T; Goto T; Taniguchi S; Yokoyama S; Ishikawa F
    Sci Transl Med; 2013 Apr; 5(181):181ra52. PubMed ID: 23596204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
    Hassane DC; Guzman ML; Corbett C; Li X; Abboud R; Young F; Liesveld JL; Carroll M; Jordan CT
    Blood; 2008 Jun; 111(12):5654-62. PubMed ID: 18305216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
    Sachlos E; Risueño RM; Laronde S; Shapovalova Z; Lee JH; Russell J; Malig M; McNicol JD; Fiebig-Comyn A; Graham M; Levadoux-Martin M; Lee JB; Giacomelli AO; Hassell JA; Fischer-Russell D; Trus MR; Foley R; Leber B; Xenocostas A; Brown ED; Collins TJ; Bhatia M
    Cell; 2012 Jun; 149(6):1284-97. PubMed ID: 22632761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
    Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
    Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia.
    Roos J; Oancea C; Heinssmann M; Khan D; Held H; Kahnt AS; Capelo R; la Buscató E; Proschak E; Puccetti E; Steinhilber D; Fleming I; Maier TJ; Ruthardt M
    Cancer Res; 2014 Sep; 74(18):5244-55. PubMed ID: 25082812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
    Jin L; Hope KJ; Zhai Q; Smadja-Joffe F; Dick JE
    Nat Med; 2006 Oct; 12(10):1167-74. PubMed ID: 16998484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
    Mahlknecht U; Schönbein C
    Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.